Showing 6851-6860 of 19322 results for "".
Emerging 'Bowel-Sparing' Procedures for Crohn's Disease
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/emerging-bowel-sparing-procedures-for-crohns-disease/10655/How can new alternatives being incorporated into surgical practice benefit your patients with Crohn's disease?Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
https://reachmd.com/programs/cme/Treatment-of-Hepatic-Encephalopathy-Primary-vs-Secondary-Prophylaxis/39791/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.The Pause: The Most Powerful Tool in Speaking
https://reachmd.com/programs/speaking-of/pause-most-powerful-tool-speaking/10109/Utilizing "the pause" correctly is key to invoking different effects and emotions in your audience.Neuroplasticity: A Potential Target for the Treatment of Depression
https://reachmd.com/programs/medical-industry-feature/neuroplasticity-potential-target-depression-treatment/29734/The brain is constantly changing as a result of experience, stress, emotional processing, learning, and memory.1 And neuroplasticity adds another layer to these approaches by focusing on what’s actually changing in the brain.2 Tune in with Dr. Charles Turck as he speaks with Dr. Madhukar Trivedi, FoThe Spectrum of Liver Transplantation: Addressing the Needs of Diverse Patient Groups
https://reachmd.com/programs/gi-insights/the-spectrum-of-liver-transplantation-addressing-the-needs-of-diverse-patient-groups/15953/Here’s what you need to know about liver transplantation across various patient populations, including those with MASLD, hepatitis, and more.How to Look Confident When Speaking
https://reachmd.com/programs/speaking-of/how-to-look-confident-when-speaking/10120/In order to come across as confident and credible among your listeners, it's essential that you use strong body language.Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
https://reachmd.com/programs/cme/scorecards-that-matter-use-mg-adl-mg-mmt-qmg-qol/51034/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
https://reachmd.com/clinical-practice/cardiology/victor-trial-results-regional-variation-in-outcomes-and-response-to-vericiguat-in-patients-with-hfref/39249/VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEFVICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF
https://reachmd.com/clinical-practice/cardiology/victor-trial-results-vericiguat-efficacy-and-safety-across-baseline-background-therapy-in-contemporary-ambulatory-patients-with-hfref/39253/VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEFTurning Flares Into Function: Flag Uncontrolled Disease
https://reachmd.com/programs/cme/turning-flares-into-function-flag-uncontrolled-disease/54770/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.